Alzheimer's Association

Alzheimer's Association 2024 Part the Cloud Gala Raises More Than $17 Million to Fund Cutting-Edge Alzheimer's and Dementia Research

Retrieved on: 
Monday, April 22, 2024

SAN FRANCISCO, April 22, 2024 /PRNewswire/ -- More than $17 million was raised Friday, April 19, at the Part the Cloud Gala, held at a private residence in Woodside, California, to fund cutting-edge Alzheimer's disease research. Started in 2012 by Michaela "Mikey" Hoag with the Alzheimer's Association, Part the Cloud is a global movement to accelerate scientific progress in Alzheimer's disease research. The evening was emceed by "Suits" star Sarah Rafferty with a musical performance by Grammy-winning multi-instrumentalist, songwriter and performer Jon Batiste.

Key Points: 
  • "In the 12 years since, Part the Cloud has bloomed into a global research movement that has the potential to find a cure for the disease."
  • Hoag elaborates, "My parents succumbed to Alzheimer's, and I wanted to do my part to change the trajectory of the disease.
  • Three clinical trials investigating promising therapies for Alzheimer's and other dementias are propelled thanks to new grant funding from Part the Cloud.
  • The funding brings Part the Cloud's total investment to $82 million in 68 groundbreaking and innovative clinical trials.

Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease

Retrieved on: 
Monday, April 22, 2024

SECAUCUS, N.J., April 22, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new blood biomarker test for phosphorylated tau 217, or p-tau217. P-tau217 is a biomarker associated with Alzheimer's Disease (AD), supported by research as useful for an early diagnosis of AD.

Key Points: 
  • P-tau217 is a biomarker associated with Alzheimer's Disease (AD), supported by research as useful for an early diagnosis of AD.
  • With a physician's test order, patients may provide a blood draw for testing from any of Quest's 2,000 patient service centers in the United States.
  • "We know diagnosing AD is challenging, and believe our AD Detect™ services can help individuals better understand their possible risk."
  • A leader in neurology, Quest Diagnostics is committed to developing innovative laboratory services to aid in evaluating patient risk of Alzheimer's Disease and other dementias.

The Alzheimer's Association® and Rippl Partner to Improve Quality Dementia Care and Caregiver Support

Retrieved on: 
Friday, April 5, 2024

CHICAGO, April 5, 2024 /PRNewswire/ -- Today, the Alzheimer's Association and Rippl announced a partnership designed to revolutionize access to high-quality dementia care across the country.

Key Points: 
  • The Dementia Care Navigation Service (DCNS), powered by Rippl and the Alzheimer's Association, leverages Rippl's proven model of on-demand dementia care and the extensive resources of the Alzheimer's Association, including its 24/7 Helpline and community education programs.
  • Millions of Americans living with dementia often face the challenge of navigating complex care landscapes without adequate support leading to poorer health outcomes, high rates of hospitalization, and significant caregiver stress.
  • 60% of health care workers believe that the U.S. health care system is not effectively helping patients and their families navigate dementia care.
  • "Our new Dementia Care Navigation Service will fill existing gaps in the care, services and support facing dementia caregivers and be a trusted partner with clinicians, hospitals and health systems," said Joanne Pike, DrPH, president and CEO, Alzheimer's Association.

New Alzheimer's Association Report Reveals Top Stressors for Caregivers and Lack of Care Navigation Support and Resources

Retrieved on: 
Wednesday, March 20, 2024

CHICAGO, March 20, 2024 /PRNewswire/ -- The Alzheimer's Association 2024 Alzheimer's Disease Facts and Figures report reveals that both dementia caregivers and health care workers report difficulties in navigating dementia care within the U.S. health care system. The report provides an in-depth look at the latest national and state-by-state statistics on Alzheimer's disease prevalence, mortality, caregiving, dementia care workforce and costs of care. The new report estimates that 6.9 million people age 65 and older in the U.S. are living with Alzheimer's dementia, with the cost of care for these individuals this year projected to reach $360 billion — a $15 billion increase from a year ago.

Key Points: 
  • This year's special report, Mapping a Better Future for Dementia Care Navigation, provides a comprehensive look into dementia care navigation by surveying dementia caregivers and health care workers on their experiences, challenges, awareness and perceptions of care navigation in dementia care.
  • Dementia care navigation provides clinical and nonclinical support to people living with dementia and their caregivers to overcome barriers that compromise care and health outcomes.
  • "Dementia care navigation programs have shown they can be a huge benefit to people living with dementia and their caregivers.
  • Get additional data and statistics from the report for Alzheimer's disease prevalence, mortality, cost of care, caregiving and dementia care workforce.

Tatango Integrates Text Messaging to Increase Fundraising for Key Nonprofits' Events

Retrieved on: 
Thursday, February 22, 2024

RALEIGH, N.C., Feb. 21, 2024 /PRNewswire-PRWeb/ -- Tatango, the leading text message platform for nonprofits, is helping iconic nonprofit organizations counter post-pandemic fundraising challenges with an ongoing rollout of fundraising-centric features in 2024. Organizations Tatango serves include March of Dimes, Alzheimer's Association, the USO, and United Women in Faith.

Key Points: 
  • Leading Text message platform allows nonprofit organizations to offset macro-trends and increase fundraising in 2024.
  • After COVID disrupted peer-to-peer fundraising and the related Run, Walk, and Ride events, mobile-centric strategies have become a critical way to recoup revenue.
  • "Tatango helps nonprofits connect with key stakeholders around events to engage participants and bolster fundraising, allowing nonprofits to rapidly execute campaigns and get the message out when it counts."
  • To access the latest research and resources on how nonprofits can increase fundraising, interested parties can learn more here: https://www.tatango.com/resources

ALZHEIMER'S ASSOCIATION MOURNS DEATH OF NEW YORK METS LEGEND BUD HARRELSON

Retrieved on: 
Thursday, January 11, 2024

CHICAGO, Jan. 11, 2024 /PRNewswire/ -- The Alzheimer's Association is deeply saddened by the death of New York Mets legend and Hall of Famer Bud Harrelson.

Key Points: 
  • CHICAGO, Jan. 11, 2024 /PRNewswire/ -- The Alzheimer's Association is deeply saddened by the death of New York Mets legend and Hall of Famer Bud Harrelson.
  • Mr. Harrelson and his family regularly partnered with the Alzheimer's Association to help reduce stigma surrounding Alzheimer's disease and elevate the conversation on behalf of the millions of families facing the disease.
  • In 2018, Harrelson was an honorary chair for the Alzheimer's Association Long Island Chapter Walk to End Alzheimer's.
  • "The Alzheimer's Association mourns the loss of New York Mets legend Bud Harrelson," said Joanne Pike, DrPH, president and CEO, Alzheimer's Association.

RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

Retrieved on: 
Thursday, November 9, 2023

PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has submitted two provisional patent applications to the US Patent Office for its investigational therapeutic drug candidates RTG-2023 and RTG-2024.

Key Points: 
  • PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has submitted two provisional patent applications to the US Patent Office for its investigational therapeutic drug candidates RTG-2023 and RTG-2024.
  • There are two forms of the disease; wet AMD and dry AMD.
  • ADI estimates there are over 10 million new cases of dementia each year worldwide, implying one new case every 3.2 seconds.
  • The Company’s novel approach includes the use of high-resolution retinal imaging and pharmacogenetic mapping to be combined with the promise of these investigational drugs.

Six-Time GRAMMY Award Winning Christian Artist Amy Grant Releases New Performance Video for Alzheimer's Association Music Moments Campaign in Honor of Her Parents

Retrieved on: 
Monday, December 18, 2023

CHICAGO, Dec. 18, 2023 /PRNewswire/ -- The Alzheimer's Association has joined forces with six-time GRAMMY Award winning Christian artist Amy Grant for its Music Moments campaign to raise awareness for Alzheimer's and other dementia this holiday season. Music Moments — a digital storytelling series — highlights the emotional connection between music and the moments in life that we never want to lose to Alzheimer's and all other dementia.

Key Points: 
  • CHICAGO, Dec. 18, 2023 /PRNewswire/ -- The Alzheimer's Association has joined forces with six-time GRAMMY Award winning Christian artist Amy Grant for its Music Moments campaign to raise awareness for Alzheimer's and other dementia this holiday season.
  • Music Moments — a digital storytelling series — highlights the emotional connection between music and the moments in life that we never want to lose to Alzheimer's and all other dementia.
  • "Music is the only gathering where everybody is on the same wavelength," Grant said.
  • Amy Grant has made a tremendous mark in the world of music, and is credited with transforming the Christian music industry.

Alzheimer's Association Mourns Death of Former Supreme Court Justice Sandra Day O'Connor

Retrieved on: 
Friday, December 1, 2023

CHICAGO, Dec. 1, 2023 /PRNewswire/ -- The Alzheimer's Association is saddened by the death of former Supreme Court Justice Sandra Day O'Connor.

Key Points: 
  • CHICAGO, Dec. 1, 2023 /PRNewswire/ -- The Alzheimer's Association is saddened by the death of former Supreme Court Justice Sandra Day O'Connor.
  • At the time of her diagnosis, Justice O'Connor was not new to Alzheimer's.
  • In 2005, as Mr. O'Connor was in decline from the disease, Justice O'Connor stepped down from the Supreme Court to spend more time with him.
  • "The Alzheimer's Association mourns the loss of former Supreme Court Justice Sandra Day O'Connor.

Ride to End Alzheimer's Spin Challenge for Giving Tuesday on November 28

Retrieved on: 
Tuesday, November 21, 2023

NEW YORK, Nov. 21, 2023 /PRNewswire/ -- For Giving Tuesday, the leaders behind Prager Metis, one of the nation's fastest growing accounting and advisory firms, will host The Accounting Industry Leadership Council Spin Challenge on Tuesday, Nov. 28. The country-wide virtual spin event will drive awareness for Alzheimer's Awareness Month while raising funding that will support the research needed to find a cure for the insidious disease.

Key Points: 
  • Peloton users joining in on the ride will be using the hashtag #Ride2EndALZ.
  • Participants who raise $100 or more will receive swag gear and earn the official Ride to End ALZ medal.
  • The Ride to End Alzheimer's Spin Challenge is led by Prager Metis Partner Wendy Valentino in honor her late mother, Jean Selwyn.
  • For CPA firms looking to further the impact, more information can be found at the Accounting Industry Leadership Council website.